User: Guest  Login
Title:

A special key for unlocking the door to targeted therapies of breast cancer.

Document type:
Journal Article; Article
Author(s):
Lindemann, K; Harbeck, N; Lengyel, E; Resau, JH
Abstract:
Personalized medicine and targeted therapy is the best hope for patients with cancer. C-Met-HGF/SF inhibition may be an effective cancer treatment for ductal carcinoma of the breast as it is expected to be an important signalling target in a large number of malignancies.
Journal title abbreviation:
ScientificWorldJournal
Year:
2008
Journal volume:
8
Pages contribution:
905-8
Language:
eng
Fulltext / DOI:
doi:10.1100/tsw.2008.110
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/18836657
TUM Institution:
Frauenklinik und Poliklinik
 BibTeX